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ABSTRACT
Quantitative culture, quantitative PCR and the galactomannan enzyme immunoassay (EIA) were
compared for their ability to determine the pulmonary fungal burden in a murine model of invasive
aspergillosis. Quantitative culture of specimens containing hyphae under-represented the absolute
fungal burden in established infection when compared with the two other methods. The best correlation
was observed between the two non-culture methods. Higher variability was observed with the
galactomannan EIA when compared with quantitative PCR. Collectively, these data suggest that
quantitative PCR is the preferred method for determination of the pulmonary fungal burden in
experimental aspergillosis.
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INTRODUCTION
The ability to accurately quantify the infectious
burden during experimental infection is critical in
the evaluation of novel therapeutics and diagnos-
tics. Quantitative culture has been the reference
standard for determining the fungal burden in
organs during infection by a variety of organisms,
including such fungal pathogens as Candida alb-
icans and Cryptococcus neoformans. Recently, con-
cern has been raised regarding the accuracy of
quantitative culture for the determination of
fungal burden in experimental infection with
ﬁlamentous fungi such as Aspergillus fumigatus
[1]. Since these organisms form aggregates of cells
within tissue by continuous extension of existing
hyphae during infection [2,3], shearing of hyphae
during mechanical disruption of tissues may
reduce the fungal viability, resulting in an
artiﬁcially low organ fungal burden. Furthermore,
incomplete homogenisation of these aggregates
may result in a failure to disperse the fungal
lesion into single organisms, leading to an under-
representation of the fungal burden by quantita-
tive culture. Thus, erroneously low quantitative
culture results have been observed in vitro with
A. fumigatus because of clumping of cells in
suspension [4]. Conversely, shearing of a single
ﬁlamentous organism into multiple fragments
could potentially cause an increase in the appar-
ent fungal burden. Indeed, it has been suggested
that therapy with caspofungin acetate, which has
been associated with hyphal fragmentation, leads
to spuriously high quantitative culture results [5].
Non-culture-based methods, including quanti-
tative PCR [6] and determination of galactoman-
nan levels by commercial enzyme immunoassays
(EIAs) [6,7], provide an alternative to quantitative
culture. These newer methods avoid many of the
problems associated with quantitative culture
from organs infected with A. fumigatus. However,
while both quantitative PCR and the galactoman-
nan EIA have been compared individually with
quantitative culture [1,8–12], these two methods
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have not been compared directly with each other.
Therefore, the present study compared quantita-
tive culture with quantitative PCR and galacto-
mannan EIA for the determination of pulmonary
fungal burden in a murine model of invasive
aspergillosis.
MATERIALS AND METHODS
Organisms
A. fumigatus AF293 (a generous gift from P. Magee, University
of Minnesota, USA) was used for all studies. For infection,
AF293 was grown for 10 days on Sabouraud dextrose plates at
37C. Conidia were harvested by ﬂooding the plates with
sterile phosphate-buffered saline supplemented with Tween-
80 0.1% v ⁄v, and were enumerated using a haemacytometer.
Animal model
To perform the most stringent evaluation of the performance
of each method, a low-dose inhalational model of murine
pulmonary aspergillosis was used. Immunosuppressed mice
were infected by aerosol chamber as described previously [3].
Brieﬂy, 2 days before infection, female Balb ⁄ c mice, weighing
18–20 g (National Cancer Institute, Bethesda, MD, USA), were
immunosuppressed with 250 mg ⁄kg of both cyclophospha-
mide (Western Medical Supply, Arcadia, CA, USA) and
cortisone acetate (Sigma-Aldrich, St Louis, MO, USA), fol-
lowed by a second dose of cyclophosphamide (200 mg ⁄ kg)
and cortisone acetate (250 mg ⁄ kg) 3 days after infection. The
mice were infected for 1 h in an inhalation chamber by
aerosolising 12 mL of a suspension of A. fumigatus conidia
containing 1 · 109 conidia ⁄mL. Groups of eight mice were
then killed humanely immediately post-infection (day 0), and
at days 3, 5 and 7 post-infection. At each time-point, two
immunosuppressed but uninfected mice were included as
negative controls. The lungs were removed by sterile dissec-
tion, weighed, added to 5 mL of NaCl 0.85% w ⁄v and
homogenised by blunt crushing in whirlbags (Fisher Scientiﬁc,
Pittsburgh, PA, USA). An aliquot from each specimen was
processed immediately for quantitative culture. Additional
aliquots were frozen for subsequent quantitative PCR and
galactomannan testing (see below). All procedures involving
mice were approved by the institutional animal use and care
committee, according to the National Institutes of Health
guidelines for animal housing and care.
Quantitative culture
Aliquots of lung homogenates were diluted serially in NaCl
0.85% w ⁄v. Each dilution (1 mL) was then overlaid with
Sabouraud dextrose agar supplemented with chloramphenicol
50 mg ⁄L. Plates were incubated for 48 h at 37C, and the
number of colonies was then counted.
Quantitative PCR
Each lung homogenate (0.1 mL) was digested and the DNA
was puriﬁed using the MasterPure Yeast kit (Epicentre,
Madison, WI, USA) and inhibitor removal resin from the
SoilMaster kit (Epicentre). The alcohol-precipitated DNA was
resuspended in 0.1 mL of 0.1 mM Tris-EDTA and then frozen
until used for PCRs. Quantitative PCR was performed as
described previously [6], except that an Aspergillus TaqMan
probe was employed (TTTCTATGATGACCCGCTCGGCA)
with a 5¢-ﬂuorescein label and a 3¢-TAMRA quencher.
This assay uses broad-range primers to amplify a 220-bp
segment of the fungal 18S rRNA gene, with detection of
A. fumigatus based on hybridisation and cleavage of the
TaqMan probe. Puriﬁed DNA (5 lL) was added to a 50-lL
PCR reaction containing Universal Master Mix (Applied
Biosystems, Warrington, UK). All samples were run in
duplicate, with the mean result being reported. Template
and digest controls were run in each batch of assays to
monitor contamination. The 45-cycle PCR comprised 15 s at
95C, 30 s at 55C and 30 s at 65C. Known quantities of
puriﬁed genomic DNA from A. fumigatus were added to PCRs
to generate a standard curve. In separate tubes, lung homo-
genate DNA (5 lL) was added to 1000 pg of A. fumigatus DNA
in order to determine whether PCR inhibitors were present in
the lung samples. The amount of A. fumigatus DNA was
assessed by comparing the ampliﬁcation threshold cycle of
the unknown sample with the threshold cycle values of
the standards.
Galactomannan enzyme immunoassay
Aliquots of the lung homogenate were vortexed and centri-
fuged (1000 g) to remove large fragments. Galactomannan was
quantiﬁed in 300-lL aliquots of homogenate using Platelia
Galactomannan EIA kits (Bio-Rad, Edmonds, WA, USA)
according to the manufacturer’s instructions [7].
Statistics
The Wilcoxon rank sum test was used to compare the
differences in fungal burden between time-points for a single
test method. Spearman’s rank correlation was used to analyse
the relationship between results obtained with the different
methods. For both tests, p £ 0.05 was considered to be
signiﬁcant.
RESULTS AND DISCUSSION
The mice were infected with conidia by inhala-
tion. Therefore, the organisms isolated from the
lungs immediately after infection (day 0) were
conidia. The conidia had germinated by the
subsequent time-points, so that essentially all of
the organisms were hyphae and virtually no
conidia were present [4]. As expected from
previous experiments [4], almost all the mice
survived for at least 7 days after inoculation. Only
a single animal died before the planned sampling
time, and this animal was excluded from the
analysis. A. fumigatus was not detected from any
uninfected mice by the quantitative culture, PCR
or quantitative galactomannan assays.
When the pulmonary fungal burden was ana-
lysed by quantitative culture, the median fungal
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burden was 1.2 · 104 CFU ⁄ g lung tissue immedi-
ately after inoculation (Fig. 1). The pulmonary
fungal burden decreased signiﬁcantly after 3 days
of infection, and remained relatively stable for the
next 4 days. This apparent drop in organ fungal
burden between day 0 and subsequent days was
probably caused by inadequate dispersion of
clumps of hyphae into single cellular elements
by the tissue homogenisation process. By virtue of
their small size, conidia are dispersed more easily,
leading to the detection of higher CFU counts.
Another potential cause of the apparent decrease
in pulmonary fungal burden at the later time-
points is that the homogenisation procedure
reduced the viability of hyphal elements through
shearing during homogenisation, although this is
less likely.
When the pulmonary fungal burden was meas-
ured by quantitative PCR, the initial organ fungal
burden was low at day 0, but increased progres-
sively throughout the experiment (Fig. 1). Because
hyphae are multicellular structures, this rise in
organ fungal burden probably reﬂects an increase
in both the number of hyphae and the number of
nuclei within the hyphae.
The pulmonary fungal burden was also low at
day 0 when it was assessed using the galacto-
mannan EIA (Fig. 1). Of the 32 specimens, 25 had
a galactomannan index above the 0.5 cut-off index
used for serum samples, with one negative
sample immediately post-infection, and two neg-
ative samples at each of the other time-points.
However, all of these values were >0.35, and the
cut-off index of 0.5 has not been evaluated for
tissue specimens. Although there was a trend
towards an increase in lung fungal burden at day
5, this increase was not signiﬁcant (p 0.19)
because of the substantial mouse-to-mouse vari-
ability in the results. However, the increase in
organ fungal burden achieved statistical signiﬁ-
cance at 7 days after infection.
Next, the results of all three methods for each
individual sample were compared directly. Since
the time course results demonstrated clearly that
quantitative culture of hyphae and conidia was
not comparable, separate analyses were per-
formed for the results of each method immedi-
ately post-infection, i.e., when the organisms
remained as conidia (Fig. 2A), and at later time-
points, when the organisms had germinated to
produce hyphae (Fig. 2B). There was poor corre-
lation among the values obtained immediately
post-infection with all of the three assays,
although the number of samples was small in
this subset analysis. The best correlation was
observed between the quantitative PCR and the
galactomannan EIA, although this correlation was
not signiﬁcant (rho 0.55; p 0.15). Interestingly, at
later time-points, when the organisms were
growing as hyphae, the relationship between
quantitative culture and either quantitative PCR
or galactomannan EIA was much more robust.
Despite the observed drop in absolute fungal
burden with quantitative culture (Fig. 1), this
method continued to allow discrimination
between high and low fungal burdens in individ-
ual samples (Fig. 2). Thus, the degree of under-
representation seems to be preserved between
individual samples, thereby providing a repro-
ducible assessment of relative, although not abso-
lute, fungal burden. Similar results were seen
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Fig. 1. Time course of fungal burden as determined by
three methods. Results are presented as median ± inter-
quartile range.
*Signiﬁcantly different (p < 0.05) from day 0 results by the
Wilcoxon rank sum test. n = eight mice for each time-
point.
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when comparing the galactomannan EIA results
with quantitative culture. Again, as with the
earlier (conidial) time-points, the highest correla-
tion was found between quantitative PCR and the
galactomannan EIA. This strong correlation
exists because both methods allow the detection
of an increasing fungal burden during the course
of infection.
The results of this study provide an insight into
the utility of quantitative culture for the deter-
mination of the relative pulmonary fungal burden
during experimental invasive aspergillosis. While
this technique clearly remains useful, and results
in less variability than either quantitative PCR or
galactomannan EIA, two important limitations
have emerged. First, quantitative culture under-
represents the absolute fungal burden when
performed after an infection is established and
the organisms have germinated. Second, the best
correlation was observed between the two non-
culture methods, particularly at time-points of
infection. In the absence of a true reference
standard, the interpretation of such comparisons
is challenging, particularly since non-culture
methods may not be able to distinguish between
live and dead organisms. However, the continued
increase in fungal burden, indicated by quantita-
tive PCR and galactomannan EIA, is much more
consistent with the histopathological course of
infection in this model, in which fungal lesions
are ﬁrst detected after 7 days of infection, and
continue to increase in size until the recovery
from neutropenia [3]. Furthermore, it is probable
that the vast majority of organisms were viable,
even after 7 days of infection, because the mice
remained profoundly neutropenic at this time-
point. Almost no leukocytes were present at foci
of pulmonary infection until after day 8 following
infection [3]. Thus, given the concordance of these
two methods, each based on the detection of a
different substrate, they seem likely to provide the
best estimate of fungal burden over time. In this
study, quantitative PCR was associated with less
sample-to-sample variability than was the galac-
tomannan EIA, suggesting that it is the preferred
method for the determination of fungal burden
after organisms have undergone germination and
are growing as hyphae.
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